Fungal rhinosinusitis (FRS) is a common problem worldwide, with an increasing burden in arid climate regions.
Aspergillus
species are the most common causative agents involved. In the present study, we investigated the prevalence, molecular characterization, and antifungal susceptibility of opportunists causing FRS in Sudan on the basis of strains collected over a period of 5 years. β-Tubulin and calmodulin sequencing were used for species identification, and antifungal susceptibility profiles were evaluated by the protocol of the European Committee on Antimicrobial Susceptibility Testing (EUCAST). Predominant species belonged to the
Aspergillus flavus
complex (
n
= 244),
A. terreus
complex (
n
= 16),
A. fumigatus
complex (
n
= 7), and other fungi (
n
= 17). Molecular identification of 94 strains of
Aspergillus
revealed the following species:
A. flavus
(
n
= 88),
A. terreus
(
n
= 1),
A. citrinoterreus
(
n
= 2),
A. fumigatus
(
n
= 1),
A. caespitosus
(
n
= 1), and
A. sydowii
(
n
= 1). Several
A. flavus
and an
A. fumigatus
isolates showed reduced susceptibility to azoles (minimum inhibitory concentrations above the clinical breakpoints or epidemiological cutoff values). Despite several mutations revealed in
cyp51A
of these isolates, none could be directly linked to azole resistance. Molecular identification of fungi causing FRS is useful to identify cryptic species and for epidemiologic studies.
IMPORTANCE
Fungal rhinosinusitis (FRS) is a significant clinical problem in arid regions. This study provides new insights into the prevalence, etiology, and antifungal susceptibility of FRS pathogens in Sudan, where the disease burden is high.
Aspergillus
species, particularly the
A. flavus
complex, were identified as the primary FRS pathogens in the region, with some evidence of antifungal resistance. The molecular identification of fungal species causing FRS is useful for detecting antifungal resistance, identifying cryptic species, and characterizing the epidemiology of the disease. The emergence of Azole resistance
Aspergilli
in Sudan highlights the need for continued surveillance and appropriate use of antifungal agents. These findings have important implications for clinical management, public health policy, and future research on FRS. Publishing this study in Microbiology Spectrum would enable other researchers and clinicians to build on these findings, ultimately improving the diagnosis, treatment, and prevention of FRS.